Omnia Medical

Executive Summary

Omnia Medical is a privately-held medical device company focused on developing innovative orthopedic implants for spine and interventional pain procedures. Founded in 2012 and headquartered in Morgantown, WV, the company aims to reduce operative time and improve surgical outcomes through novel product designs. Its portfolio includes systems for sacroiliac (SI) joint stabilization, cervical and lumbar interbody fusion, and bone graft solutions. The company operates in the growing orthopedic and cardiovascular device market, targeting conditions that affect millions of patients annually. With a focus on minimally invasive techniques, Omnia Medical addresses unmet needs in spinal fusion and pain management, areas that continue to see technological advancement and increasing adoption. As a private entity with limited public disclosures, Omnia Medical's financial details and valuation remain undisclosed. The company's competitive position is bolstered by its specialized product offerings and potential for regulatory clearances from the FDA. The spine device market is highly competitive, with incumbents like Medtronic and NuVasive, but niche innovators can capture share through differentiated technology. Omnia Medical's ability to secure FDA 510(k) clearances, achieve clinical validation, and attract strategic partnerships will be critical to its growth trajectory. The company is likely in a growth stage, seeking to expand its commercial footprint through product development and commercialization efforts.

Upcoming Catalysts (preview)

• Q2 2026FDA 510(k) Clearance for Expanded SI Joint Stabilization System70% success
• Q4 2025Completion of Series B Funding Round60% success
• Q1 2027Clinical Study Results for Cervical Fusion Implant50% success